Analyst Ratings for Astria Therapeutics (ATXS)
ATXS Rating Summary
ATXS Price Target Summary
- Highest: $26.00 (Evercore ISI)
- Lowest: $13.00 (Jefferies)
- Average: $17.33
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$17.33 (+37.8%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Avg. $ Target:
$17.33 (+37.8%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/12/2025 | Cantor Fitzgerald | Steven Seedhouse | Downgrade | Neutral (Overweight) |
N/A (N/A) |
12.51 (12.58) |
0.56% | Details |
| 10/16/2025 | H.C. Wainwright | Joseph Pantginis | Downgrade | Neutral (Buy) |
N/A (N/A) |
11.92 (12.58) |
5.54% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
